PhRMA Blasts Poll About Gov’t Drug Price Negotiation Support
October
14
With Congress continuing to debate a measure that would allow the Medicare program to negotiate drug prices with manufacturers, a new Kaiser Family Foundation (KFF) poll has found that “large majorities” of U.S. adults support such a move, “and this support holds steady even after the public is provided the arguments being presented by parties on both sides of the legislative debate.”
But the Pharmaceutical Research and Manufacturers of America (PhRMA) is striking back, with a spokesperson sending an email to reporters on Oct. 12 that accuses KFF of “joining the partisan fray and political advocacy groups who are trying desperately to build congressional support for government price-setting.”
© 2022 MMIT
Meet Our Reporters
-
Angela Maas Managing Editor, RADAR on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and RADAR on Drug Benefits
View Leslie Small's Profile -
Lauren Flynn Kelly Managing Editor, RADAR on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Peter Johnson Reporter, Health Plan Weekly and RADAR on Drug Benefits
View Peter Johnson's Profile -
Tim Casey Reporter, Health Plan Weekly and RADAR on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, RADAR on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and RADAR on Drug Benefits
View Jinghong Chen's Profile -
Jill Brown Kettler Executive Editor
View Jill Brown Kettler's Profile